消化

订阅

MedSci主页 / 所有栏目 / 消化

肠化生不典型增生可逆转吗？

2021-07-29 MedSci原创 MedSci原创

肺癌诊疗
关注

肠化生不典型增生可逆转吗？-实用教程——如何提高早期胃癌检出率？-问题6.

《梅斯直播课：实用教程——如何提高早期胃癌检出率》

回答问题6：肠化生不典型增生可逆转吗？

 

欢迎点赞、评论、分享

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1970315, encodeId=425019e03157d, content=<a href='/topic/show?id=bc8d202929a' target=_blank style='color:#2F92EE;'>#不典型增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20292, encryptionId=bc8d202929a, topicName=不典型增生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Mon Jul 11 18:22:08 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898664, encodeId=7816189866469, content=<a href='/topic/show?id=e5062028978' target=_blank style='color:#2F92EE;'>#不典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20289, encryptionId=e5062028978, topicName=不典型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Thu Jan 06 10:22:08 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510772, encodeId=1b671510e72f9, content=<a href='/topic/show?id=64f2815401a' target=_blank style='color:#2F92EE;'>#肠化生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81540, encryptionId=64f2815401a, topicName=肠化生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb810243780, createdName=楚钟, createdTime=Sat Jul 31 02:22:08 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003575, encodeId=3c6e10035e5ab, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/9ea48fa6c8404748b9be19b76af70207/9485e2ffb6e04c8aab6c266b042ad435.jpg, createdBy=c59a5539406, createdName=ms2000001248344936, createdTime=Thu Jul 29 12:11:23 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2022-07-11 zhishijing

    #不典型增生#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1970315, encodeId=425019e03157d, content=<a href='/topic/show?id=bc8d202929a' target=_blank style='color:#2F92EE;'>#不典型增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20292, encryptionId=bc8d202929a, topicName=不典型增生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Mon Jul 11 18:22:08 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898664, encodeId=7816189866469, content=<a href='/topic/show?id=e5062028978' target=_blank style='color:#2F92EE;'>#不典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20289, encryptionId=e5062028978, topicName=不典型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Thu Jan 06 10:22:08 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510772, encodeId=1b671510e72f9, content=<a href='/topic/show?id=64f2815401a' target=_blank style='color:#2F92EE;'>#肠化生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81540, encryptionId=64f2815401a, topicName=肠化生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb810243780, createdName=楚钟, createdTime=Sat Jul 31 02:22:08 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003575, encodeId=3c6e10035e5ab, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/9ea48fa6c8404748b9be19b76af70207/9485e2ffb6e04c8aab6c266b042ad435.jpg, createdBy=c59a5539406, createdName=ms2000001248344936, createdTime=Thu Jul 29 12:11:23 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2022-01-06 yaanren

    #不典型#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1970315, encodeId=425019e03157d, content=<a href='/topic/show?id=bc8d202929a' target=_blank style='color:#2F92EE;'>#不典型增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20292, encryptionId=bc8d202929a, topicName=不典型增生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Mon Jul 11 18:22:08 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898664, encodeId=7816189866469, content=<a href='/topic/show?id=e5062028978' target=_blank style='color:#2F92EE;'>#不典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20289, encryptionId=e5062028978, topicName=不典型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Thu Jan 06 10:22:08 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510772, encodeId=1b671510e72f9, content=<a href='/topic/show?id=64f2815401a' target=_blank style='color:#2F92EE;'>#肠化生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81540, encryptionId=64f2815401a, topicName=肠化生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb810243780, createdName=楚钟, createdTime=Sat Jul 31 02:22:08 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003575, encodeId=3c6e10035e5ab, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/9ea48fa6c8404748b9be19b76af70207/9485e2ffb6e04c8aab6c266b042ad435.jpg, createdBy=c59a5539406, createdName=ms2000001248344936, createdTime=Thu Jul 29 12:11:23 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2021-07-31 楚钟

    #肠化生#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1970315, encodeId=425019e03157d, content=<a href='/topic/show?id=bc8d202929a' target=_blank style='color:#2F92EE;'>#不典型增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20292, encryptionId=bc8d202929a, topicName=不典型增生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Mon Jul 11 18:22:08 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898664, encodeId=7816189866469, content=<a href='/topic/show?id=e5062028978' target=_blank style='color:#2F92EE;'>#不典型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20289, encryptionId=e5062028978, topicName=不典型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Thu Jan 06 10:22:08 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510772, encodeId=1b671510e72f9, content=<a href='/topic/show?id=64f2815401a' target=_blank style='color:#2F92EE;'>#肠化生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81540, encryptionId=64f2815401a, topicName=肠化生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb810243780, createdName=楚钟, createdTime=Sat Jul 31 02:22:08 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003575, encodeId=3c6e10035e5ab, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/9ea48fa6c8404748b9be19b76af70207/9485e2ffb6e04c8aab6c266b042ad435.jpg, createdBy=c59a5539406, createdName=ms2000001248344936, createdTime=Thu Jul 29 12:11:23 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2021-07-29 ms2000001248344936

    学习

    0

相关资讯

段建春教授：精准医学时代下的肺癌诊疗新进展

在精准医学的时代下，肺癌的诊疗均不断趋向精准化，其中液体活检在肺癌早期诊断、疗效及复发监测中具有重要应用价值。免疫检查点抑制剂作为肺癌精准治疗的重要组成部分，PD-1/PD-L1抑制剂已被FDA批准用于非小细胞肺癌（NSCLC）的治疗。

拓展阅读

查出萎缩性胃炎伴肠化生，50岁阿姨失声痛哭！其实......

萎缩性胃炎伴不同程度的肠化生，在中老年人当中非常常见，虽然它与胃癌并没有直接的关联，但是很多人胃镜查出来后，还不免忧心忡忡。

认识肠化生，癌前病变并非癌症！

患者王女士，刚过不惑之年，有多年的慢性浅表性胃炎病史。平时生活规律，饮食起居有度，并坚持定期到医院检查身体。近来天气转冷，感上腹部不适，进食后饱胀、打嗝、嗳气不断，又来医院就诊。

Gastrointest Endosc：内镜治疗肠化生完全缓解后复发率高

美国一项研究表明，内镜治疗肠化生完全缓解(CRIM)后复发率高，因此，CRIM后的持续监测很有必要。论文发表于《消化内镜》杂志6月刊[Gastrointest Endosc2016，83(6)：1090]。 该研究检索多个数据库中内镜治疗CRIM后的长期随访研究，估算CRIM后复发性肠化生、不典型增生Barrett食管和高度不典型增生(HGD)或食管腺癌(EAC)每人-年随访的汇总发病率，评估

时永全：胃黏膜肠化生临床研究进展

胃黏膜肠化生（IM）是指胃黏膜上皮细胞被肠型上皮细胞所替代的一种病理状态。按照肠化生细胞表达小肠酶的差异，IM可以分为完全型和不完全型，按照肠化生细胞的病理形态可以分为小肠型和大肠型，按照肠化生细胞在胃腺体细胞中所占的比例可以分为轻、中、重度。由于肠化生是常见的胃黏膜癌前病变，其防治研究日益受到关注。 大量的流行病学资料表明，在接受胃镜检查者中，10%以上的患者存在IM。2014年，我国